References
- Widmann FK, ed. AABB technical manual. 9th ed. Arlington. VA: Am Assoc of Blood Banks. 1985
- Centers for Disease Control. Transfusion malaria: serologic identification of infected donors: Pennsylvania. Georgia. MMWR 1983: 32(17): 222–9
- Mollison PL. Blood transfusion in clinical medicine. 7th ed. Boston: Blackwell Scientific Publications. 1983
- Braine HG, Kickler TS, Charache P. et al. Bacterial sepsis secondary to platelet transfusion: an adverse effect of extended storage at room temperature. Transfusion 1986: 26(4): 391–3
- Heal JM, Singal S, Sardisco E, et al. Bacterial proliferation in platelet concentrates. Transfusion 1986: 26(4): 388–90
- Polesky HF, Hanson M. Transfusion-associated hepatitis: a dilemma. Lab Med 1983: 14(11): 717–20
- Roeckel IE, Watts WT. Prevalence of post-transfusion non-A. non-B hepatitis. Pathologist 1986: 40(7): 6–7
- Wick MR. Moore S, Taswell HF. Non-A. non-B hepatitis associated with blood transfusion. Transfusion 1985: 25(2): 93–101
- Hoofnagle JH. Type A and type B hepatitis. Lab Med 1983: 14(11): 705–16
- Buchner BK, Moore BP. Prevalence of delta agent among Canadian blood donors. (Letter) Transfusion 1986: 26(4): 400
- Rosina F. Saracco G, Rizzetto M. Risk of post-transfusion infection with the hepatitis delta virus: a multicenter study. N Engl J Med 1985: 312(23): 1488–91
- Aach RD, Szmuness W, Mosley JW, et al. Serum alanine aminotransferase of donors in relation to the risk of non-A. non-B hepatitis in recipients: the transfusion-transmitted viruses study. N Engl J Med 1981: 304(17): 989–94
- Sampliner RE, Beluk D, Harrow EJ, et al. The persistence and significance of elevated alanine aminotransferase levels in blood donors. Transfusion 1985: 25(2): 102–4
- Koziol DE, Holland PV, Alling DW, et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986: 104(4): 488–95
- Yeager AS, Grumet FC, Hafleigh EB, et al. Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr 1981: 98(2): 281–7
- Demmler GJ, Brady MT, Bijou H, et al. Post-transfusion cytomegalovirus infection in neonates: role of saline-washed red blood cells. J Pediatr 1986: 108(5 Pt 1): 762–5
- Bove JR. The response to AIDS. (Editorial) Transfusion 1985: 25(1): 1–2
- Centers for Disease Control. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associatedvirus infections. MMWR 1986: 35(20): 334–9
- Peterman TA, Jaffe HW, Feorino PM, et al. Transfusion-associated acquired immunodeficiency syndrome in the United States. JAMA 1985: 254(20): 2913–7
- Jaffe HW, Sarngadharan MG, DeVico AL, et al. Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome: serologic evidence of an association. JAMA 1985: 254(6): 770–3
- Feorino PM, Jaffe HW, Palmer E, et al. Transfusion-associated acquired immunodeficiency syndrome: evidence for persistent infection in blood donors. N Engl J Med 1985: 312(20): 1293–6
- Pindyck J, Waldman A, Zang E, et al. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion: evidence of volunteer blood donor cooperation. Transfusion 1985: 25(1): 3–9
- Centers for Disease Control. Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor: Colorado. JAMA 1986: 256(5): 574–5
- Grindon AJ. Efficacy of voluntary self-deferral of donors at high risk of AIDS. (Abstr) Transfusion 1984: 24: 434
- Kolins J. The continued risk of transfusion-transmitted AIDS. Pathologist 1986: 40(6): 9–10
- Ward JW, Grindon AJ, Feorino PM, et al. Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III. JAMA 1986: 256(3): 357–61
- Corran JW, Morgan WM, Hardy AM, et al. The epidemiology of AIDS: current status and future prospects. Science 1985: 229(4720): 1352–7
- Department of Health and Human Services. Safety of immune globulins in relation to HTLV-IIII. FDA Drug Bull 1986: 16(1): 3
- Francis DP, Feorino PM, McDongal S, et al. The safety of hepatitis B vaccine: inactivation of the AIDS virus during routine vaccine manufacture. JAMA 1986: 256(7): 869–72
- Iwarson S, Steen Y, Rybo G, et al. Does Cohn-fractionated Rh immune globulin transmit viral hepatitis? Transfusion 1985: 25(1): 15–7
- Department of Health and Human Services. Safety of hepatitis B vaccine confirmed. FDA Drug Bull 1985: 15(2): 14–5